Venous Malformation
A venous malformation is a congenital abnormality of the veins in which clusters of abnormally formed, dilated venous channels develop in the skin, soft tissues, muscles, bones, or internal organs. Venous malformations are present from birth but may not become noticeable until later in life. They can range from small and asymptomatic to large lesions that cause pain, swelling, disfigurement, or functional impairment. MRI is the most useful imaging tool for diagnosis and characterization, and treatment is highly individualized—often combining sclerotherapy, surgery, medications, and supportive care delivered by specialized vascular anomaly teams.
What is it?
The body’s blood vessels form during early fetal development as a complex network of arteries, veins, capillaries, and lymphatic channels. Sometimes this process does not occur normally, resulting in a vascular malformation—a localized abnormality of blood or lymphatic vessels. A venous malformation specifically involves abnormally formed and dilated venous channels, often with slow blood flow within them. These channels can group together to form a cluster, a more diffuse network, or extend through one or more tissue layers. Venous malformations are the most common type of vascular malformation.
Venous malformations are present from birth, although they may not become noticeable until later in childhood, adolescence, or adulthood, particularly during periods of growth, hormonal change, trauma, or pregnancy. They are distinct from common “birthmarks” such as port-wine stains (capillary malformations) and from infantile hemangiomas, which are tumors that grow rapidly in infancy and typically regress. They are also distinct from arteriovenous malformations (high-flow lesions involving abnormal connections between arteries and veins) and lymphatic malformations, although mixed forms can occur.
Most venous malformations are sporadic and develop because of changes in certain genes (such as TIE2/TEK and PIK3CA) within the cells of the abnormal vessels themselves. Some, including familial cutaneomucosal venous malformations and glomuvenous malformations, are inherited. Larger or more extensive venous malformations may be part of broader syndromes—such as blue rubber bleb nevus syndrome, CLOVES syndrome, and Klippel-Trénaunay syndrome—that can involve multiple tissues or organs.
The appearance and symptoms of a venous malformation depend on its size, depth, and location. Lesions in the skin and soft tissues typically appear as soft, compressible, bluish swellings that can enlarge with crying, exercise, lying down, or pressure-increasing maneuvers. Lesions can affect any part of the body but are particularly common in the head and neck and in the extremities. Common symptoms include pain (especially after activity or at the end of the day), swelling, a feeling of fullness or pressure, episodes of clot formation within the malformation (a process called localized intravascular coagulation), morning stiffness, and—in lesions involving joints—reduced range of motion. Lesions on the lips, tongue, or in the mouth can cause difficulty with eating, speaking, or breathing. Lesions in the gastrointestinal tract can cause chronic bleeding and iron deficiency anemia. Lesions involving bone can cause structural changes and pain.
Clotting within venous malformations is common and can produce painful, firm areas (phleboliths) that often calcify and can be seen on imaging. Although the small clots typically do not break off and travel to the lungs, larger lesions—particularly those in the deep veins or with extensive networks—can be associated with elevated risk of more significant clotting events, especially with surgery, immobilization, or pregnancy.
Diagnosis is usually made through a combination of clinical examination and imaging. Ultrasound is often the initial imaging study and shows characteristic findings such as compressible, slow-flow vascular channels. MRI is the most useful imaging test for detailed characterization, mapping the extent of the malformation, evaluating involvement of nearby structures (such as muscle, bone, joints, and nerves), and planning treatment. CT can show calcified phleboliths and bone involvement. Diagnostic venography or angiography is sometimes performed at the time of planned treatment to characterize flow patterns. Blood tests may show elevated D-dimer levels, reflecting clot turnover within the malformation. Genetic testing may be considered in selected familial or extensive cases.
Important to Know
Management of venous malformations is highly individualized and depends on the size, location, symptoms, and impact on function. Care is typically delivered by multidisciplinary vascular anomaly teams that may include interventional radiology, vascular medicine, plastic and reconstructive surgery, dermatology, hematology, orthopedic surgery, head and neck surgery, pediatric specialists, and genetic counseling, among others.
Small, asymptomatic venous malformations often require no specific treatment beyond reassurance and periodic follow-up. Supportive measures—such as compression garments for lesions in the extremities, elevation, activity modification, and pain management with appropriate medications—can be very helpful for symptomatic lesions. Aspirin or other agents are sometimes used to reduce clotting within the malformation.
For symptomatic or disfiguring lesions, image-guided sclerotherapy is one of the most common treatments. In this procedure, a specialized solution is injected directly into the malformation under imaging guidance, causing the abnormal venous channels to scar and shrink. Multiple sessions are often required, and outcomes depend on the type, location, and extent of the malformation. Surgery is reserved for selected cases—either alone or in combination with sclerotherapy—and may be used for well-defined lesions, residual disease after sclerotherapy, or specific anatomic considerations. Laser therapy can be helpful for superficial lesions.
Targeted medical therapies have become an increasingly important option for selected patients. Medications that target the abnormal cellular signaling pathways underlying many venous malformations—such as sirolimus and, more recently, specific PI3K and AKT inhibitors—are being used in extensive, refractory, or syndromic cases under specialized care.
Management of complications—such as pain, clotting, bleeding, infection, or pressure on nearby structures—is an important part of care. Patients with extensive venous malformations may also require careful planning around surgery, anesthesia, pregnancy, and travel, given the risk of clotting events.
Venous malformations generally persist throughout life. Even when treatment is successful, periodic follow-up is often needed to monitor for changes and to address recurrent or new symptoms. Patients with familial forms or syndromic conditions may benefit from genetic counseling and screening of family members.
Red flag symptoms include sudden severe pain or swelling at the site of a known venous malformation, signs of infection (such as redness, warmth, fever), severe bleeding, sudden difficulty breathing or swallowing (particularly with lesions of the airway, head, or neck), sudden severe leg pain or swelling (which may suggest deep vein thrombosis), chest pain or shortness of breath (which may suggest pulmonary embolism), or sudden neurological symptoms. These warrant prompt or urgent medical evaluation.